Please login to the form below

Not currently logged in
Email:
Password:

Fasenra

This page shows the latest Fasenra news and features for those working in and with pharma, biotech and healthcare.

AZ raises full-year guidance after completing Alexion acquisition in Q2

AZ raises full-year guidance after completing Alexion acquisition in Q2

AstraZeneca has delivered another period of strong growth thanks to robust performances across all regions and disease areas, particularly oncology, new CVRM and Fasenra in respiratory.

Latest news

More from news
Approximately 7 fully matching, plus 19 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...